This week's Fierce Drug Delivery is brought to you by Thermo Fisher Scientific.
Oral solid dose (OSD) formulations continue to lead the market as a preferred drug form. The efficiency, cost effectiveness, shelf stability, and ease of administration of OSDs contribute to the appeal of the platform for enhancing existing formulations and transforming newer therapeutics such as peptides and biologics.
The webinar will provide insight into the critical importance of patient centricity in OSD development, focusing on:
- New controlled-release technologies
- Formulation strategies to enhance solubility
- Application of modified delivery approaches
- Innovative dose forms to new molecules
|
| You are currently subscribed as newsletter@newslettercollector.com |
